Ferrer I - Search Results

1

Neurochemistry and the non-motor aspects of PD.

Ferrer I, López-Gonzalez I, Carmona M, Dalfó E, Pujol A, Martínez A. Ferrer I, et al. Neurobiol Dis. 2012 Jun;46(3):508-26. doi: 10.1016/j.nbd.2011.10.019. Neurobiol Dis. 2012. PMID: 22737710 Review.

2

Chandelier cell axons identified by parvalbumin-immunoreactivity in the normal human temporal cortex and in Alzheimer's disease.

Fonseca M, Soriano E, Ferrer I, Martinez A, Tuñon T. Fonseca M, et al. Neuroscience. 1993 Aug;55(4):1107-16. doi: 10.1016/0306-4522(93)90324-9. Neuroscience. 1993. PMID: 8232900

3

CREB-1 and CREB-2 immunoreactivity in the rat brain.

Ferrer I, Blanco R, Rivera R, Carmona M, Ballabriga J, Olivé M, Planas AM. Ferrer I, et al. Brain Res. 1996 Mar 11;712(1):159-64. doi: 10.1016/0006-8993(95)01527-2. Brain Res. 1996. PMID: 8705300

4

Transforming growth factor-alpha (TGF-alpha) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain.

Ferrer I, Alcántara S, Ballabriga J, Olivé M, Blanco R, Rivera R, Carmona M, Berruezo M, Pitarch S, Planas AM. Ferrer I, et al. Prog Neurobiol. 1996 Jun;49(2):99-123. doi: 10.1016/0301-0082(96)00009-3. Prog Neurobiol. 1996. PMID: 8844822 Review.

5

Prion protein expression in senile plaques in Alzheimer's disease.

Ferrer I, Blanco R, Carmona M, Puig B, Ribera R, Rey MJ, Ribalta T. Ferrer I, et al. Acta Neuropathol. 2001 Jan;101(1):49-56. doi: 10.1007/s004010000271. Acta Neuropathol. 2001. PMID: 11194941

6

Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, Puig B, Rey MJ, Cardozo A, Viñals F, Ribalta T. Ferrer I, et al. Brain Pathol. 2001 Apr;11(2):144-58. doi: 10.1111/j.1750-3639.2001.tb00387.x. Brain Pathol. 2001. PMID: 11303790 Free PMC article.

7

Fas and Fas ligand expression in Alzheimer's disease.

Ferrer I, Puig B, Krupinsk J, Carmona M, Blanco R. Ferrer I, et al. Acta Neuropathol. 2001 Aug;102(2):121-31. doi: 10.1007/s004010000325. Acta Neuropathol. 2001. PMID: 11563626

8

Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat.

Ferrer I, Blanco R, Carmona M. Ferrer I, et al. Brain Res Mol Brain Res. 2001 Oct 19;94(1-2):48-58. doi: 10.1016/s0169-328x(01)00198-x. Brain Res Mol Brain Res. 2001. PMID: 11597764

9

Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

Ferrer I, Blanco R, Carmona M, Puig B. Ferrer I, et al. Neuropathol Appl Neurobiol. 2001 Oct;27(5):343-51. doi: 10.1046/j.1365-2990.2001.00348.x. Neuropathol Appl Neurobiol. 2001. PMID: 11679086

10

Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.

Ferrer I, Blanco R, Carmona M, Puig B, Barrachina M, Gómez C, Ambrosio S. Ferrer I, et al. J Neural Transm (Vienna). 2001;108(12):1383-96. doi: 10.1007/s007020100015. J Neural Transm (Vienna). 2001. PMID: 11810403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,368 results

Search Page

Filters